The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 23, 2017

Filed:

Mar. 13, 2012
Applicants:

Yeon Soo Kim, Seoul, KR;

Moon Kyung Kang, Daejeon, KR;

A Young Song, Ulsan, KR;

Inventors:

Yeon Soo Kim, Seoul, KR;

Moon Kyung Kang, Daejeon, KR;

A Young Song, Ulsan, KR;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); A61K 35/76 (2015.01); A61K 38/16 (2006.01); A61K 38/45 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 35/76 (2013.01); A61K 38/162 (2013.01); A61K 38/45 (2013.01); A61K 48/00 (2013.01); C12N 2740/10032 (2013.01); C12N 2740/10043 (2013.01); C12N 2740/13045 (2013.01); C12N 2740/13052 (2013.01); C12N 2800/40 (2013.01); C12N 2800/50 (2013.01); C12Y 207/01021 (2013.01);
Abstract

The present invention provides a vector system in which a MuLV-Gag gene, a MuLV-Pol gene, and a GaLV-Env gene are expressed in two separate vectors. The vector system is capable of inserting a therapeutic gene to these two separate vectors, and in this raged, the size of an inserted gene is not limited and a variety of foreign therapeutic genes may be inserted to the vectors. Accordingly, the foreign therapeutic gene may be delivered in a safe and efficient manner to desired tissue of cells of aberrant proliferation. Therefore, the vector system is applicable in a composition for delivering a gene targeting the aberrantly dividing cells of aberrant proliferation, wherein the composition includes a retrovirus produced by cell line transfection. The vector system is also applicable in a composition for preventing or treating a disease caused by cells of aberrant proliferation of, such as cancer cells.


Find Patent Forward Citations

Quick Actions:

Kim, Yeon. (2017). Replication competent pseudo-type retrovirus vector system (U.S. Patent No. 9657312). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9657312

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…